Dietary Guidelines for Patients with Severe Gastroparesis

Introduction to Dietary Management

For patients with severe gastroparesis, hypoalbuminemia, and impaired renal function on dialysis, a low-fat liquid diet with small, frequent meals is strongly recommended as the optimal approach to improve nutritional status and reduce symptoms 1

For patients with gastroparesis unresponsive to prokinetic treatment, nasojejunal tube feeding is preferable to overcome gastric emptying issues 1, 2
Late evening oral nutritional supplements (ONS) can help reduce overnight catabolism without reducing normal food consumption during the day 1, 3

Energy intake: 35 kcal/kg body weight/day is recommended for stable patients on dialysis 2, 4
Protein intake: 1.2-1.3 g/kg body weight/day for metabolically stable dialysis patients 5
For acutely ill dialysis patients, protein intake may need to be higher (1.5 g/kg/day) but must be balanced with dialysis adequacy 5
Monitor phosphorus and potassium content in foods and supplements, as these need to be restricted in dialysis patients 2, 3

ONS should be the preferred route in conscious hemodialysis patients with poor oral intake 1, 4
ONS should be given 2-3 hours after usual meals to avoid nutritional substitution 1
Hemodialysis-specific formulas should be preferred for tube feeding, while standard ONS can be used for oral supplementation 3, 4
Intradialytic delivery of ONS has been associated with better compliance 1

If gastroparesis remains unresponsive to prokinetic treatment, consider nasojejunal tube feeding rather than nasogastric feeding 1, 2
For long-term feeding in severe cases, placement of percutaneous endoscopic jejunostomy (PEJ) should be considered 1, 4

Regular monitoring of serum albumin levels is essential as it is a predictor of mortality risk in dialysis patients 6
Monitor for hypophosphatemia during refeeding, especially when using electrolyte-restricted formulas 1
Assess nutritional status regularly using body mass index (BMI), serum albumin, and body weight changes 6

The European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines recommend renal-specific oral nutritional supplements with concentrated calories, higher protein content, and reduced electrolyte content for patients on dialysis, particularly those with electrolyte imbalances, fluid overload, or high protein needs 7, 8
Renal-specific supplements should be strongly preferred in patients with electrolyte imbalances, such as hyperkalemia or hyperphosphatemia, and in those with fluid overload requiring restriction 7, 8
The American Society of Nephrology and the National Kidney Foundation suggest that standard oral supplements can be used in patients with well-controlled electrolytes, no fluid restrictions, and adequate dialysis clearance 7, 8

Renal-specific formulas provide higher calorie density, advantageous calorie-to-protein ratio, and reduced potassium and sodium content, making them suitable for patients with high protein needs and electrolyte disturbances 7, 8
The ESPEN guidelines explicitly state that disease-specific formulas should not be routinely utilized in every patient and their use must be individualized based on calorie-to-protein ratio needs and clinical status 7, 8, 9

The ESPEN guidelines advise against using omega-3 enriched formulas routinely, as there is insufficient evidence to support their routine use in hospitalized dialysis patients 7, 8, 9
High-dose parenteral glutamine is contraindicated in critically ill patients with kidney failure, according to the Clinical Nutrition guidelines 8

The European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines establish that renal-specific formulas like Nepro should not be routinely prescribed to every dialysis patient, but rather their use must be individualized based on three key clinical factors, including calorie-to-protein ratio needs, electrolyte disturbances, and fluid overload 10, 11
Renal-specific formulas provide concentrated calories (1.5-2.0 kcal/ml) with higher protein density, making them advantageous for patients requiring high protein intake (1.2-1.3 g/kg/day for stable dialysis patients) while managing fluid restrictions 10, 12
Nepro contains reduced sodium, potassium, and phosphorus content, making it preferable for patients with hyperkalemia or hyperphosphatemia 10, 11

The American Society for Parenteral and Enteral Nutrition recommends individualized nutrition support for dialysis patients, considering factors such as calorie and protein needs, electrolyte balance, and fluid status 10, 11
Intensive dietary counseling targeting 30-35 kcal/kg/day energy and 1.2-1.3 g/kg/day protein is recommended as first-line therapy for dialysis patients 10, 12

The European Society for Clinical Nutrition and Metabolism (ESPEN) recommends a hierarchical approach to nutrition support in dialysis patients, starting with intensive dietary counseling and adding oral nutritional supplements (such as Nepro) if necessary 10, 11

The National Kidney Foundation recommends monitoring serum albumin and prealbumin monthly as markers of nutritional response in dialysis patients 10, 11
Potassium and phosphorus levels should be monitored to ensure electrolyte control is maintained in dialysis patients using Nepro 10, 11